Non-genotoxic conditioning facilitates hematopoietic stem cell gene therapy for hemophilia A using bioengineered factor VIII is a research paper published in Molecular Therapy — Methods & Clinical Development (2021). On theSindex it has a DataRank of 0.416. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: P30CA138292
National Heart, Lung, and Blood Institute
Grant: U54 HL141981
NHLBI NIH HHS
Grant: K08 HL141635
National Institutes of Health
Grant: 5P30CA138292-11
Winship Cancer Institute Cancer Center Support Grant
National Institutes of Health
Grant: 5U54HL141981-03
Unraveling the immune response to factor VIII
Winship Cancer Institute
Hemophilia of Georgia
National Institutes of Health
Children's Healthcare of Atlanta
FWCI
0.57
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals